GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinopharm Group Co Ltd (OTCPK:SHTDF) » Definitions » 5-Year Yield-on-Cost %

Sinopharm Group Co (Sinopharm Group Co) 5-Year Yield-on-Cost %

: 6.42 (As of Today)
View and export this data going back to 2009. Start your Free Trial

Sinopharm Group Co's yield on cost for the quarter that ended in Sep. 2023 was 6.42.


The historical rank and industry rank for Sinopharm Group Co's 5-Year Yield-on-Cost % or its related term are showing as below:

SHTDF' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 4.54   Med: 6.25   Max: 8.61
Current: 6.42


During the past 13 years, Sinopharm Group Co's highest Yield on Cost was 8.61. The lowest was 4.54. And the median was 6.25.


SHTDF's 5-Year Yield-on-Cost % is ranked better than
87.1% of 62 companies
in the Medical Distribution industry
Industry Median: 3.76 vs SHTDF: 6.42

Competitive Comparison

For the Medical Distribution subindustry, Sinopharm Group Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinopharm Group Co 5-Year Yield-on-Cost % Distribution

For the Medical Distribution industry and Healthcare sector, Sinopharm Group Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Sinopharm Group Co's 5-Year Yield-on-Cost % falls into.



Sinopharm Group Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Sinopharm Group Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Sinopharm Group Co  (OTCPK:SHTDF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Sinopharm Group Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Sinopharm Group Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinopharm Group Co (Sinopharm Group Co) Business Description

Traded in Other Exchanges
Address
No. 385, East Longhua Road, Sinopharm Group Building, Huangpu District, Shanghai, CHN, 200023
Sinopharm Group was founded in 2003 and listed on the Hong Kong Stock Exchange in September 2009. Its main business is drug distribution in mainland China, which contributes about 75% of total revenue. It is the largest drug distributor, with approximately 20% market share. Other notable segments are medical device distribution, which contributes about 20% of revenue, and retail pharmacies, which contributes about 5%. These are fast-growing industries, where government policy is designed to encourage consolidation and promote large players with scale and efficiency advantages.

Sinopharm Group Co (Sinopharm Group Co) Headlines

From GuruFocus

Matthews China Fund Comments on Sinopharm

By Sydnee Gatewood Sydnee Gatewood 01-25-2021

Matthews China Fund 1st Quarter Commentary

By Holly LaFon Holly LaFon 05-19-2016

Matthews China Fund Q3 2014 Commentary

By Holly LaFon Holly LaFon 10-18-2014

Matthews China Fund Comments on Sinopharm

By Holly LaFon Holly LaFon 05-19-2016

Matthews China Fund Comments on Sinopharm

By Sydnee Gatewood Sydnee Gatewood 07-30-2020

Matthews China Fund Comments on Sinopharm Group

By Vera Yuan Vera Yuan 10-20-2014